INNOVATE Corp

VATE

Market cap $68.3M

INNOVATE Corp. ( VATE ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Neel Sikka Paul Voigt - Interim Chief Executive Officer Michael Sena - CFO, Treasurer & Corporate Secretary Presentation Operator Good afternoon, and welcome to the INNOVATE Corp Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

- Infrastructure: DBM Global delivers robust revenue growth, reinforcing market leadership - - Life Sciences: MediBeacon received regulatory approval to sell the Transdermal GFR System in China - - Spectrum: New network launches underway; F ourth quarter advertising sales showing early signs of recovery -

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2025 on Wednesday, November 12, 2025, after market close. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 4:30 p.m. ET.

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, has received approval from the National Medical Products Administration (NMPA) for Lumitrace® (relmapirazin) injection, a non-radioactive, non-iodinated fluorescent GFR agent. Lumitrace will be sold as an integral component of the Transdermal GFR System in China.

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE, will pay a cash dividend of approximately $8.8 million, or $2.28 per share, on November 10, 2025 to DBMG's stockholders of record at the close of business on October 27, 2025. As the largest stockholder of DBMG, INNOVATE expects to receive approximately $8 million of the total $8.8 million dividend payout. INNOVATE's individual stockholders are not eligible to receive the cash dividend.

NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that R2 Technologies, Inc. (“R2”), the innovators behind the breakthrough Glacial® Skin technology, and an operating subsidiary of INNOVATE, achieved a second-quarter 2025 revenue increase of 88% over the same quarter in 2024. This strong performance underscores R2's accelerating momentum in the global aesthetics market.

INNOVATE Corp. (NYSE:VATE ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Michael J. Sena - CFO, Treasurer & Corporate Secretary Neel Sikka - Corporate Participant Paul Kenneth Voigt - Interim Chief Executive Officer Operator Good afternoon, and welcome to INNOVATE Corp.'s Second Quarter 2025 Earnings Conference Call.

- Infrastructure: Improved financial flexibility with recent refinancing transactions - - Life Sciences: R2 continuing to see significant year over year growth in system unit sales - - Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier -

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced that it has closed a series of previously announced indebtedness refinancing transactions that will, among other things, exchange or amend existing instruments representing 81.7% of the total outstanding principal amount of the Company's debt as of June 30, 2025 for instruments with longer maturities. The refinancing transactions include (i) the initial closing of an exchange offer and consent solicitation with respect to the Company's senior secured notes, (ii) privately negotiated exchanges of certain of the Company's convertible senior notes, (iii) amendment and extension of the Company's 2020 Revolving Credit Agreement (as defined below), (iv) amendment and extension of the Company's Continental General Insurance Company (“CGIC”) note, as well as the exchange of a portion of the Company's preferred stock held by CGIC in exchange for increasing the principal amount of that note, (v) amendment and extension of the Spectrum Notes (as defined below) and (vi) amendment and extension of the R2 Technologies Note (as defined below).

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) today announced the early participation results as of 5:00 p.m., New York City time, on July 30, 2025 (the “Early Participation Deadline”) of its previously announced exchange offer and consent solicitation (the “Exchange Offer”) to eligible holders of its 8.5% Senior Secured Notes due 2026 (the “Existing Senior Secured Notes”) to exchange such Existing Senior Secured Notes for newly issued 10.5% Senior Secured Notes due 2027 (the “New Senior Secured Notes”). Additionally, the Company today announced that it will extend eligibility to receive the Total Early Exchange Consideration (as defined below) in the Exchange Offer through the Expiration Deadline (as defined below).